61 related articles for article (PubMed ID: 23881352)
21. Oncologic outcomes after minimally invasive radical prostatectomy in patients with seminal vesicle invasion (pT3b) without adjuvant therapy.
Forgues A; Rozet F; Audenet F; Ouzzane A; Sanchez-Salas R; Barret E; Galiano M; Prapotnich D; Cathelineau X
World J Urol; 2014 Apr; 32(2):519-24. PubMed ID: 23881352
[TBL] [Abstract][Full Text] [Related]
22. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
[TBL] [Abstract][Full Text] [Related]
23. Seminal vesicle involvement after radical prostatectomy: predicting risk factors for progression.
Salomon L; Anastasiadis AG; Johnson CW; McKiernan JM; Goluboff ET; Abbou CC; Olsson CA; Benson MC
Urology; 2003 Aug; 62(2):304-9. PubMed ID: 12893340
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of seminal vesicle involvement due to prostate cancer in radical prostatectomy specimens.
Algarra R; Barba J; Merino I; Tienza A; Tolosa E; Robles JE; Zudaire J
Actas Urol Esp; 2015 Apr; 39(3):144-53. PubMed ID: 24996780
[TBL] [Abstract][Full Text] [Related]
25. Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy.
Fossati N; Karnes RJ; Cozzarini C; Fiorino C; Gandaglia G; Joniau S; Boorjian SA; Goldner G; Hinkelbein W; Haustermans K; Tombal B; Shariat S; Karakiewicz PI; Montorsi F; Van Poppel H; Wiegel T; Briganti A
Eur Urol; 2016 Apr; 69(4):728-733. PubMed ID: 26497924
[TBL] [Abstract][Full Text] [Related]
26. Prognostic indicators in patients with seminal vesicle involvement following radical prostatectomy for clinically localized prostate cancer.
Tefilli MV; Gheiler EL; Tiguert R; Banerjee M; Sakr W; Grignon DJ; Pontes JE; Wood DP
J Urol; 1998 Sep; 160(3 Pt 1):802-6. PubMed ID: 9720552
[TBL] [Abstract][Full Text] [Related]
27. Outcome predictors of radical prostatectomy followed by adjuvant androgen deprivation in patients with clinical high risk prostate cancer and pT3 surgical margin positive disease.
Spahn M; Briganti A; Capitanio U; Kneitz B; Gontero P; Karnes JR; Schubert M; Montorsi F; Scholz CJ; Bader P; van Poppel H; Joniau S;
J Urol; 2012 Jul; 188(1):84-90. PubMed ID: 22578727
[TBL] [Abstract][Full Text] [Related]
28. Seminal vesicle invasion: what is the best adjuvant treatment after radical prostatectomy?
Bastide C; Rossi D; Lechevallier E; Bladou F; Barriol D; Bretheau D; Grisoni V; Mancini J; Giusiano S; Eghazarian C; Van Hove A
BJU Int; 2012 Feb; 109(4):525-30; discussion 531-2. PubMed ID: 21851534
[TBL] [Abstract][Full Text] [Related]
29. Accuracy of high resolution (1.5 tesla) pelvic phased array magnetic resonance imaging (MRI) in staging prostate cancer in candidates for radical prostatectomy: results from a prospective study.
Renard-Penna R; Rouprêt M; Comperat E; Ayed A; Coudert M; Mozer P; Xylinas E; Bitker MO; Grenier P
Urol Oncol; 2013 May; 31(4):448-54. PubMed ID: 21775172
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant androgen deprivation for high-risk prostate cancer after radical prostatectomy: SWOG S9921 study.
Dorff TB; Flaig TW; Tangen CM; Hussain MH; Swanson GP; Wood DP; Sakr WA; Dawson NA; Haas NB; Crawford ED; Vogelzang NJ; Thompson IM; Glode LM
J Clin Oncol; 2011 May; 29(15):2040-5. PubMed ID: 21502546
[TBL] [Abstract][Full Text] [Related]
31. A contemporary analysis of outcomes of adenocarcinoma of the prostate with seminal vesicle invasion (pT3b) after radical prostatectomy.
Pierorazio PM; Ross AE; Schaeffer EM; Epstein JI; Han M; Walsh PC; Partin AW
J Urol; 2011 May; 185(5):1691-7. PubMed ID: 21419448
[TBL] [Abstract][Full Text] [Related]
32. Impact of adjuvant androgen deprivation therapy after radical prostatectomy on the survival of patients with pathological T3b prostate cancer.
Siddiqui SA; Boorjian SA; Blute ML; Rangel LJ; Bergstralh EJ; Karnes RJ; Frank I
BJU Int; 2011 Feb; 107(3):383-8. PubMed ID: 21265985
[TBL] [Abstract][Full Text] [Related]
33. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease.
Heidenreich A; Bellmunt J; Bolla M; Joniau S; Mason M; Matveev V; Mottet N; Schmid HP; van der Kwast T; Wiegel T; Zattoni F;
Eur Urol; 2011 Jan; 59(1):61-71. PubMed ID: 21056534
[TBL] [Abstract][Full Text] [Related]
34. Endorectal magnetic resonance imaging has limited clinical ability to preoperatively predict pT3 prostate cancer.
Brajtbord JS; Lavery HJ; Nabizada-Pace F; Senaratne P; Samadi DB
BJU Int; 2011 May; 107(9):1419-24. PubMed ID: 20804475
[TBL] [Abstract][Full Text] [Related]
35. Biochemical recurrence after radical prostatectomy: multiplicative interaction between surgical margin status and pathological stage.
Budäus L; Isbarn H; Eichelberg C; Lughezzani G; Sun M; Perrotte P; Chun FK; Salomon G; Steuber T; Köllermann J; Sauter G; Ahyai SA; Zacharias M; Fisch M; Schlomm T; Haese A; Heinzer H; Huland H; Montorsi F; Graefen M; Karakiewicz PI
J Urol; 2010 Oct; 184(4):1341-6. PubMed ID: 20723925
[TBL] [Abstract][Full Text] [Related]
36. Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era.
Stephenson AJ; Kattan MW; Eastham JA; Bianco FJ; Yossepowitch O; Vickers AJ; Klein EA; Wood DP; Scardino PT
J Clin Oncol; 2009 Sep; 27(26):4300-5. PubMed ID: 19636023
[TBL] [Abstract][Full Text] [Related]
37. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95.
Wiegel T; Bottke D; Steiner U; Siegmann A; Golz R; Störkel S; Willich N; Semjonow A; Souchon R; Stöckle M; Rübe C; Weissbach L; Althaus P; Rebmann U; Kälble T; Feldmann HJ; Wirth M; Hinke A; Hinkelbein W; Miller K
J Clin Oncol; 2009 Jun; 27(18):2924-30. PubMed ID: 19433689
[TBL] [Abstract][Full Text] [Related]
38. Seminal vesicle invasion in radical prostatectomies: which is the most common route of invasion?
Billis A; Teixeira DA; Stelini RF; Quintal MM; Guimarães MS; Ferreira U
Int Urol Nephrol; 2007; 39(4):1097-102. PubMed ID: 17431809
[TBL] [Abstract][Full Text] [Related]
39. A UK-based investigation of inter- and intra-observer reproducibility of Gleason grading of prostatic biopsies.
Melia J; Moseley R; Ball RY; Griffiths DF; Grigor K; Harnden P; Jarmulowicz M; McWilliam LJ; Montironi R; Waller M; Moss S; Parkinson MC
Histopathology; 2006 May; 48(6):644-54. PubMed ID: 16681679
[TBL] [Abstract][Full Text] [Related]
40. Cancer-specific survival and predictors of prostate-specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy.
Secin FP; Bianco FJ; Vickers AJ; Reuter V; Wheeler T; Fearn PA; Eastham JA; Scardino PT
Cancer; 2006 Jun; 106(11):2369-75. PubMed ID: 16649221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
